Spectrum Advisory Services’s Teva Pharmaceuticals TEVA Stock Holding History

Spectrum Advisory Services’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,450	Closed	-$226K	–	155
2015 Q4	$226K	Buy	+3,450	New	+$213K	0.09%	134
2015 Q3	–	Sell	-4,629	Closed	-$274K	–	156
2015 Q2	$274K	Sell	4,629 -381	-8%	-$23.5K	0.1%	130
2015 Q1	$312K	Hold	5,010	–	–	0.11%	131
2014 Q4	$288K	Hold	5,010	–	–	0.1%	137
2014 Q3	$269K	Hold	5,010	–	–	0.1%	145
2014 Q2	$263K	Hold	5,010	–	–	0.09%	145
2014 Q1	$265K	Hold	5,010	–	–	0.09%	143
2013 Q4	$201K	Sell	5,010 -1,805	-26%	-$71.1K	0.07%	166
2013 Q3	$257K	Sell	6,815 -3,000	-31%	-$117K	0.1%	144
2013 Q2	$385K	Buy	+9,815	New	+$382K	0.16%	125

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Spectrum Advisory Services's TEVA Position: Q1 2016 in Review

Spectrum Advisory Services sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 3,450 shares — an estimated $226K sold.

Spectrum Advisory Services first reported a position in TEVA in Q2 2013 and held it in 10 quarters. The position peaked at $385K in Q2 2013. 836 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Spectrum Advisory Services reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Spectrum Advisory Services sold 3,450 Teva Pharmaceuticals shares in Q1 2016, an estimated $226K.
Spectrum Advisory Services first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 10 quarters.
Spectrum Advisory Services's Teva Pharmaceuticals position peaked at $385K in Q2 2013.
836 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on Spectrum Advisory Services's 13F filing for Q1 2016, filed 12 May 2016.